Search

everythinglearnresearchcommunity

for

Search:↓

Certain immune cells contribute to severe hair loss in chronic alopecia areata, with Th17 cells possibly having a bigger impact than cytotoxic T cells.

Follicular mycosis fungoides can look like a B-cell lymphoma, making diagnosis difficult.

HIV patients with lower CD4 T cell counts often have more skin problems.

T-regulatory cells are important for skin health and can affect hair growth and reduce skin inflammation.

Activating TLR9 helps heal wounds and regrow hair by using specific immune cells.

The COVID-19 pandemic led to fewer patient visits, more visits by older adults, an increase in cutaneous T-cell lymphoma cases, and a rise in noncosmetic procedures at a dermatology clinic.

Lichen planopilaris may be an autoimmune disease causing hair loss due to immune system issues in hair follicles.

CRAC channels are crucial for the development and function of specialized immune cells, preventing severe inflammation and autoimmune diseases.

Dihydrotestosterone (DHT) doesn't affect rat skin cell growth, but it does change cell cycle, protein levels, and other cell functions, potentially shortening hair growth cycle.

Simvastatin helps hair regrowth in autoimmune alopecia by directly affecting T cells.

MDSC-Exo can treat autoimmune alopecia areata and promote hair regrowth in mice.

RANKL improves the immune response against herpes simplex virus by enhancing T cell activation and could help develop better treatments or vaccines.

Low serum complement levels in SLE patients don't always match with disease flares; monitoring C3 and C4 is useful, but cell-bound complement products might better indicate disease activity.

Severe alopecia areata involves higher levels of certain immune cells, which can be normalized with betamethasone.

A protein called EGFR protects hair follicle stem cells, and when it's disrupted, hair follicles can be damaged, but blocking certain pathways can restore hair growth.

The review suggests that other immune cells besides CD8+ T cells may contribute to alopecia areata and that targeting regulatory cell defects could improve treatment.

Special immune cells called Regulatory T cells help control skin inflammation and repair in various skin diseases.

Stem cell research and regenerative medicine have made significant advancements in treating various diseases and conditions.

IL-17 and certain immune cells are linked to more severe alopecia areata.

Memory T cells in the skin balance staying put and moving into the blood, clustering around hair follicles, and increasing in number after infection.

A gene mutation in mice causes increased mast cells and disorganized hair follicles in their skin.

Early regulatory T cells are crucial for normal skin pigmentation.

γδTregs may help treat autoimmune diseases like alopecia areata by promoting hair regrowth and reducing immune attacks.

Tissue-resident memory T cells can protect against infections and cancer but may also contribute to autoimmune diseases.

Lack of Vitamin D receptor changes skin structure and increases certain immune cells in the skin.

BST2 protein and certain T cells increase in early alopecia areata.

In June 2019, the stem cell research field saw major progress, including new clinical trials, FDA approvals, and industry collaborations.

Herpes gestationis is linked to certain antigens, atopic eczema affects T cell populations and may be eased by breastfeeding, higher doses of anti-androgen treatment can improve androgenic alopecia, topical minoxidil increases hair thickness, long-term methotrexate therapy can cause liver fibrosis in psoriasis patients, and Lichen Sclerosus et Atrophicus patients aren't at higher risk for autoimmune disorders.

The document concludes that more research is needed to reduce frequent hospital visits, addiction medicine education improves with specific training, early breast cancer surgery findings are emerging, nipple smears are not very accurate, surgery for older melanoma patients doesn't extend life, a genetic condition in infants can often be treated with one drug, doctors are inconsistent with blood clot medication, a certain gene may protect against cell damage, muscle gene overexpression affects many other genes, and some mitochondrial genes are less active in mice with tumors.

The document concludes that better targeted treatments are needed for wound healing, and single-cell technologies may improve cell-based therapies.